Singapore SME Innovation Support Schemes - PRO INNO Europe
Singapore SME Innovation Support Schemes - PRO INNO Europe
Singapore SME Innovation Support Schemes - PRO INNO Europe
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
od of 3 to 12 months. Companies are given the option to license the technology if the<br />
development project is successful. Essentially Exploit is taking the risk of proving the<br />
technology to a commercial ready state. This can be particularly beneficial if the potential<br />
licensees are <strong>SME</strong>s as they are generally not ready to take on the commercialisation<br />
of a technology unless it is proven.<br />
Exploit also operates a business incubation process, which attempts to identify new<br />
technologies at an early stage in the research and direct the development of these with<br />
commercialisation firmly in mind. These are likely to be technologies which can have<br />
multiple and cross-disciplinary applications and have the potential to grow into new<br />
industrial sectors. These are referred to as flagship projects and Exploit can provide<br />
S$3 – 5 million (€1.8 - 3milliom) to fund the business incubation of these technologies.<br />
Researchers can submit a proposal to Exploit for this flagship funding.<br />
Exploit also work closely with large multinational companies to translate technologies<br />
into application, through a research collaboration agreement. In this case the company<br />
would license the technology from A*Star. Exploit maintains and advertises (through<br />
Tech Alerts and RSS feeds) a database of A*Star technologies which are ready for commercialisation.<br />
Exploit has a standard license agreement which it provides online, and licensing agreements<br />
can be concluded in a matter of weeks if companies agree to these standard<br />
terms. Exclusive or non-exclusive licenses can be granted, however exclusive licenses<br />
might only be granted in cases where technology requires substantial development, or<br />
investment. Exclusive licenses might typically be restricted to specific fields of use, geographic<br />
areas, and/or time periods. The right to further develop the technology is usually<br />
retained by Exploit and typically there is no exclusive access granted to any further<br />
future A*Star developments of the technology.<br />
Exploit looks at the IP portfolio and examines it for commercial opportunities. In doing<br />
this it doesn’t have a particular bias towards the creation of spin-outs or serving <strong>SME</strong>s as<br />
opposed to large companies as it needs to be aware of its mission to serve all industry<br />
through the licensing of IP. Licensing seems to be the more usual route for commercial<br />
exploitation, with spin-offs being the more unusual. Licensing terms to industry are generally<br />
flexible. In terms of the number of licenses more go to <strong>SME</strong>s than large companies,<br />
however in terms of the value of licenses large companies account for the greatest share.<br />
Licensing is looked at in a flexible manner where the goal is very much financial benefit<br />
to <strong>Singapore</strong> as opposed to benefit to any one research institute or organisation and Exploit<br />
would be conscious that there must be a balance struck in this regard.<br />
Exploit currently manages a portfolio of over 3000 active patents, have granted over<br />
250 licenses, and have a portfolio of 24 spin-off companies. The estimated business revenues<br />
arising from the A*Star licensed technologies is S$500 million (€300 million). The<br />
total market value created though A*Star start-ups amounts to more than S$100 million<br />
(€60 million).<br />
PAGE 22<br />
www.proinno-europe.eu/partnering-forum